Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant genetic disorders. The aim of our study was to evaluate post-traumatic stress disorder (PTSD) in patients and their families following the disclosure of sporadic NF1. Diagnosis of NF1 was retained according to NIH criteria, familial forms were excluded. The French version of the Impact of Event Scale-Revised was used for the diagnosis of PTSD.
Neurofibromatosis 1|Diagnoses Disease|Post Traumatic Stress Disorder
Study post traumatic stress disorder secondary to annoucement of diagnosis of neurofibromatosis type 1 in de novo form, Questionnaire Impact of Event Scale, Day 1 after diagnosis of neurofibromatosis
Study methods of annoucement and feeling of patients with a questionnaire, Questionnaires about: methods of announcement (who? when? how?), Day 1 after diagnosis of neurofibromatosis|Genetical analyze, Genetical analyze, Day 1 after diagnosis of neurofibromatosis|Psychological or psychiatrical impact, Psychological or psychiatrical impact, Day 1 after diagnosis of neurofibromatosis|Information about NF1, Questions about look for information about disease, Day 1 after diagnosis of neurofibromatosis
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant genetic disorders. The aim of our study was to evaluate post-traumatic stress disorder (PTSD) in patients and their families following the disclosure of sporadic NF1. Diagnosis of NF1 was retained according to NIH criteria, familial forms were excluded. The French version of the Impact of Event Scale-Revised was used for the diagnosis of PTSD.